Hui Zhou

Principal Scientist, ModeX Therapeutics

Hui Zhou is Principal Scientist at ModeX Therapeutics, where he leads analytical development for multispecific therapeutics. With over 15 years of experience in mass spectrometry, biotherapeutics characterization and antibody engineering, his expertise spans analytical platform development, bioconjugation and glycoproteomics, supporting the advancement of next-generation biologics from discovery through development.

Seminars

Wednesday 18th November 2026
Using High-Resolution Mass Spectrometry to Characterize Next- Generation Targeted LNPs
4:40 pm
  • Apply high-resolution mass spectrometry to simultaneously characterize lipid, RNA, antibody, and conjugate components within targeted LNP systems
  • Quantify conjugation efficiency, assess conjugation site specificity, and investigate product-related heterogeneity impacting therapeutic performance
  • Establish comprehensive analytical workflows to support discovery, process development, and CMC readiness for targeted LNP therapeutics
Hui Zhou
View all Speakers
View Event Brochure